one transient flatulence case
This activity of GLP-1 has been demonstrated in both preclinical and clinical studies, and the results support the hypothesis that the GLP-1 pathway regulates the processes of alcohol use disorder (AUD)
Eric Achten, orcid.org/0000-0002-5148-4178
As in prior experiments with GEP44, no indicators of nausea or malaise (e.g., changes in responsiveness, behavior, coat appearance, or facial expressions such as orbital tightening and nose/cheek flattening) were observed with GEP12 dosing
Enhanced endothelial cell proliferation, migration, and tube formation were observed in laboratory studies accompanying the animal experiments
At the same time, various research and developments are also being conducted to identify new applications and to develop next-generation GLP-1 drugs